Cover Image

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Sophia M. Abusamra, Verónica Ochoa Cholán, Veda N. Giri, Susan T. Vadaparampil, Verónica Pérez‐Rosas, Adrian Rivera, Tatiana Sanchez Nolasco, Mariana Rangel Camacho, Nataliya Byrne, Stacy Loeb
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	BJUI Compass
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
by: Ryan Sutherland, et al.
Published: (2024)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
by: Kunal K. Sindhu, et al.
Published: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
by: Eric Margolis, et al.
Published: (2025)

Emerging tools for the early detection of prostate cancer
by: Muhammad Haider, et al.
Published: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
by: Esther H. J. Hamoen, et al.
Published: (2025)

Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
by: Oluwafolajimi Adesanya, et al.
Published: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
by: Mohammed Shahait, et al.
Published: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
by: Ailene E. Corona, et al.
Published: (2026)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
by: Arjun Pon Avudaiappan, et al.
Published: (2024)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
by: Abel Tesfai, et al.
Published: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
by: Eric V. Li, et al.
Published: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
by: Nikhil Mayor, et al.
Published: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
by: Nadia Rokan, et al.
Published: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
by: Ruth Pidsley, et al.
Published: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
by: Geneva Pantoja, et al.
Published: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
by: Sofia Mesquita, et al.
Published: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
by: Samantha Shekar, et al.
Published: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
by: Jonathon Dawson, et al.
Published: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
by: Marcus Sondermann, et al.
Published: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
by: Muhammad Haider, et al.
Published: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
by: Muhammad Imran, et al.
Published: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
by: Sandra Irenaeus, et al.
Published: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
by: Alan Priester, et al.
Published: (2024)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
by: Austin Drysch, et al.
Published: (2025)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
by: Jennifer Dunsmore, et al.
Published: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
by: Herbert Lepor, et al.
Published: (2025)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
by: Maxwell Louis Sandberg, et al.
Published: (2026)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
by: Ali H. Zahalka, et al.
Published: (2024)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
by: See‐Tong Pang, et al.
Published: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
by: Agnieszka Krzyzanowska, et al.
Published: (2024)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
by: Abel Tesfai, et al.
Published: (2024)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
by: Nicole Handa, et al.
Published: (2025)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
by: Lisa Browning, et al.
Published: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
by: Mohammadmehdi Adhami, et al.
Published: (2026)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
by: Stijn M. van den Bosch, et al.
Published: (2026)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
by: Yuki Teramoto, et al.
Published: (2026)

A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility
by: Lorenzo Storino Ramacciotti, et al.
Published: (2024)

Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
by: Stephen Langley, et al.
Published: (2024)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
by: Jeremy Cheng, et al.
Published: (2025)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
by: Angelo Porreca, et al.
Published: (2025)